Dopamine modified plasma matrix, plasma matrix bone block and preparation method thereof

By adding dopamine to the plasma matrix and combining Bio-Oss bone meal, plasma matrix bone blocks with high crosslinking and good mechanical properties were prepared, which solved the problem of insufficient bone block strength in the prior art and achieved better transplantation Bone effect and biocompatibility.

CN119075009APending Publication Date: 2024-12-06HUBEI PRIME SHIELD BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411290560.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-14
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing plasma matrix bone blocks have problems of insufficient cross-linking and insufficient tensile strength, making it difficult to effectively maintain the shape of the bone graft body and solve the problem of vertical bone increment.

Method used

By adding dopamine to the plasma matrix, dopamine-modified plasma matrix and bone blocks are prepared by using various methods to improve their cross-linking degree and mechanical properties, including spraying, injection, soaking and other methods, and bone blocks are prepared in combination with Bio-Oss bone meal. .

Benefits of technology

The degree of cross-linking and mechanical properties of plasma matrix are improved, the toughness and tensile strength of bone mass are enhanced, and the problems of insufficient cross-linking and insufficient strength are solved, while maintaining good biocompatibility and osteogenic efficacy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0005044450170000011
    Figure HDA0005044450170000011
  • Figure HDA0005044450170000012
    Figure HDA0005044450170000012
  • Figure HDA0005044450170000021
    Figure HDA0005044450170000021
Patent Text Reader

Abstract

The invention relates to a dopamine modified plasma matrix, a plasma matrix bone block and a preparation method thereof. The preparation method of the dopamine-modified plasma matrix comprises the following steps: preparing the dopamine-modified plasma matrix through interaction of dopamine and the plasma matrix; wherein the plasma matrix comprises at least one of a liquid plasma matrix and a solid plasma matrix. The dopamine modified plasma matrix obtained by the preparation method disclosed by the embodiment of the invention has relatively high crosslinking degree and good mechanical properties.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to a dopamine-modified plasma matrix, a plasma matrix bone block and a preparation method thereof. Background Art

[0002] Adequate bone volume is a key factor for the success of oral implant surgery. However, a series of factors such as tooth infection, alveolar damage, tooth extraction or periodontal disease can lead to local or extensive bone defects in the alveolar process. Autologous bone transplantation is the gold standard for bone augmentation surgery. However, this method is subject to some limitations, such as the need for secondary surgery, limited amount of tissue available, and increased risk of infection or recurrent pain. A variety of biomaterials have been shown to help repair or replace damaged bone tissue (autologous bone, allogeneic bone, biomaterials, etc.).

[0003] The application of autologous blood extracts in wound healing and tissue regeneration is currently a hot topic in the research of bioregenerative materials. It comes from the body itself, does not cause rejection reactions in the body, and has a good regeneration effect. Platelet-rich plasma (PRP) and second-generation plasma matrix (PRF) are concentrated by taking blood to obtain products rich in platelets and fibrin. Due to their superior biological effects, they are used in many clinical fields.

[0004] Granular autologous grafts, xenografts or synthetic grafts have been successfully used to cover small bone defects on the implant surface. However, granular bone grafts are not suitable for vertical bone grafting due to the difficulty in maintaining the shape of the bone graft and the leakage of particles in the surgical area. In recent years, a new type of artificial bone block with fast coagulation time, good biocompatibility and good mechanical properties has been prepared by combining solid plasma matrix, liquid plasma matrix and Bio-Oss bone powder. This bone block can cross-link the bone substitute material in the fiber network and maintain its implantation morphology, which is conducive to solving the problem of vertical bone augmentation that is difficult to solve clinically. However, this bone block has problems such as insufficient cross-linking and insufficient tensile strength. Summary of the invention

[0005] In order to solve at least one of the above technical problems, the present invention provides a dopamine-modified plasma matrix, a plasma matrix bone block and a preparation method thereof. The dopamine-modified plasma matrix of the embodiment of the present invention has a high degree of cross-linking and good mechanical properties.

[0006] As one aspect, the present invention provides a method for preparing a dopamine-modified plasma matrix, which comprises any one of the following methods I to III: Method I: spraying or injecting dopamine into a blood collection tube to obtain a blood collection tube containing dopamine; adding blood to the blood collection tube containing dopamine, centrifuging, and obtaining a dopamine-modified plasma matrix; or, Method II: placing blood in a blood collection tube, centrifuging, and obtaining a solid plasma matrix; soaking the solid plasma matrix in a dopamine solution to obtain a dopamine-modified plasma matrix; or, Method III: placing blood in a blood collection tube, centrifuging, and obtaining a liquid plasma matrix; and mixing dopamine and the liquid plasma matrix evenly to obtain a dopamine-modified plasma matrix.

[0007] In some embodiments of the present invention, in method I, the ratio of the mass of dopamine to the volume of blood ranges from (100 ng:10 mL) to (10 μg:10 mL), for example, it can be 156 ng:10 mL, 283 ng:10 mL, 439 ng:10 mL, 958 ng:10 mL, 5.2 μg:10 mL, 8.2 μg:10 mL, 9.7 μg:10 mL, etc.

[0008] In some embodiments of the present invention, in method II, the concentration range of the dopamine solution is 10 μmol / L to 500 μmol / L, for example, it can be selected from 86 μmol / L, 128 μmol / L, 297 μmol / L, 356 μmol / L, 412 μmol / L, 458 μmol / L, 476 μmol / L, 497 μmol / L, etc.; the mass ratio of the solid plasma matrix to the volume ratio of the dopamine solution is in the range of (5 g:1 mL) to (15 g:1 mL), for example, it can be 5.8 g:1 mL, 6.9 g:1 mL, 8.7 g:1 mL, 9.6 g:1 mL, 11.7 g:1 mL, 13.8 g:1 mL, 14.9 g:1 mL, etc.

[0009] In some embodiments of the present invention, in method III, the mass ratio of dopamine to the mass ratio of liquid plasma matrix is ​​in the range of (100ng:10g) to (10μg:10g), for example, it can be selected from 158ng:10g, 286ng:10g, 458ng:10g, 958ng:10g, 5.2μg:10g, 8.2μg:10g, 9.7μg:10g, etc.

[0010] In some embodiments of the present invention, the centrifugal acceleration of the centrifuge is 20-1000g, for example, 89g, 206g, 396g, 489g, 693g, 879g, 946g, etc.; the centrifugal time is 5-10min; for example, 5.2min, 6.4min, 7.9min, 8.6min, 9.2min, 9.8min, etc. Preferably, the centrifugal acceleration of the centrifuge is 20-950g, for example, 29g, 326g, 476g, 598g, 683g, 869g, 976g, etc.; the centrifugal time is 2-8min, for example, 2.5min, 3.9min, 4.8min, 5.3min, 6.8min, 7.9min, etc.

[0011] In some embodiments of the present invention, the material used to prepare the blood collection tube is selected from plastic or glass.

[0012] As another aspect, the present invention provides a dopamine-modified plasma matrix, and the dopamine-modified plasma matrix is ​​obtained using the above-mentioned preparation method.

[0013] As another aspect, the present invention provides a method for preparing a dopamine-modified plasma matrix bone block, comprising: placing blood in a blood collection tube, centrifuging, and obtaining a solid plasma matrix and a liquid plasma matrix respectively; mixing the solid plasma matrix, the liquid plasma matrix, dopamine, and Bio-Oss bone powder to prepare a dopamine-modified plasma matrix bone block; wherein the mass ratio of the solid plasma matrix, the liquid plasma matrix, dopamine, and the Bio-Oss bone powder is in the range of (5g to 10g ):(1mL~2mL):(10ng~50μg):0.25g. For example, the mass ratio between the four can be: 5.9g:1.2mL:39ng:0.25g, 6.5g:1.3mL:898ng:0.25g, 7.6g:1.6mL:26μg:0.25g, 8.3g:1.7mL:32μg:0.25g, 9.6g:1.9mL:48μg:0.25g, etc.

[0014] In some embodiments of the present invention, the process includes: placing a first volume of blood in a glass blood collection tube and centrifuging to obtain a liquid plasma matrix; placing a second volume of blood in a plastic blood collection tube and centrifuging to obtain a solid plasma matrix; pressing the solid plasma matrix into a plasma matrix membrane in a pressing device box; cutting the plasma matrix membrane into pieces to obtain plasma matrix membrane fragments; mixing dopamine and Bio-Oss bone powder to obtain a mixture of dopamine and Bio-Oss bone powder; and uniformly mixing the mixture of dopamine and Bio-Oss bone powder, plasma matrix membrane fragments, and liquid plasma matrix to obtain dopamine-modified plasma matrix bone blocks.

[0015] As another aspect, the present invention provides a dopamine-modified plasma matrix bone block, which is obtained by using the above-mentioned method for preparing the dopamine-modified plasma matrix bone block.

[0016] The technical solution of the embodiment of the present invention has the following advantages:

[0017] The method for preparing the dopamine-modified plasma matrix of the embodiment of the present invention prepares the dopamine-modified plasma matrix through the interaction between dopamine and the plasma matrix. The dopamine-modified plasma matrix has a high degree of cross-linking and good mechanical properties. The plasma matrix products (e.g., plasma matrix membranes, plasma matrix bone blocks, and plasma matrix liquids, etc.) prepared from the dopamine-modified plasma matrix of the embodiment of the present invention have high mechanical properties and biological properties (e.g., osteogenic properties). BRIEF DESCRIPTION OF THE DRAWINGS

[0018] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and, together with the description, serve to explain the principles of the invention.

[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0020] Figure 1 This is a schematic flow chart of a method for preparing a dopamine-modified plasma matrix bone block according to an embodiment of the present invention;

[0021] Figure 2 This is a comparison chart of the tensile strength of the dopamine-modified plasma matrix prepared in Example 1 of the present invention and the plasma matrix prepared in Comparative Example 1;

[0022] Figure 3 This is a physical picture of the dopamine-modified plasma matrix bone block prepared in Example 2 of the present invention;

[0023] Figure 4 This is a comparison chart of the tensile strength of the dopamine-modified plasma matrix bone block prepared in Example 2 of the present invention and the plasma matrix bone block prepared in Comparative Example 2. DETAILED DESCRIPTION

[0024] In order to more clearly understand the above-mentioned objectives, features and advantages of the present invention, the scheme of the present invention will be further described below. It should be noted that the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

[0025] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein; it is obvious that the embodiments in the specification are only part of the embodiments of the present invention, rather than all of the embodiments.

[0026] According to an embodiment of the present invention, a method for preparing a dopamine-modified plasma matrix is ​​provided, and the preparation method comprises any one of the following methods I to III: Method I: spraying or injecting dopamine into a blood collection tube to obtain a blood collection tube containing dopamine; adding blood to the blood collection tube containing dopamine, centrifuging, and obtaining a dopamine-modified plasma matrix; or, Method II: placing blood in a blood collection tube, centrifuging, and obtaining a solid plasma matrix; soaking the solid plasma matrix in a dopamine solution to obtain a dopamine-modified plasma matrix; or, Method III: placing blood in a blood collection tube, centrifuging, and obtaining a liquid plasma matrix; and mixing dopamine and the liquid plasma matrix evenly to obtain a dopamine-modified plasma matrix.

[0027] In some embodiments of the present invention, the dopamine-modified plasma matrix includes but is not limited to at least one of the following forms: a dopamine-modified liquid plasma matrix, a dopamine-modified solid plasma matrix, and a dopamine-modified plasma matrix membrane.

[0028] In some embodiments of the present invention, a method for preparing a dopamine-modified plasma matrix comprises the following steps:

[0029] (1) spraying dopamine in a blood collection tube, sterilizing and vacuum treating the tube, and obtaining a blood collection tube containing dopamine;

[0030] Preferably, the material used to prepare the blood collection tube is selected from plastic or glass.

[0031] (2) collecting 7 to 50 mL of blood into the blood collection tube in step (1);

[0032] Preferably, the ratio of the mass of dopamine in step (1) to the volume of blood in step (2) is in the range of (100 ng:10 mL) to (10 μg:10 mL).

[0033] (3) mixing the blood collection tube containing blood obtained in step (2) uniformly, and centrifuging at a centrifugal acceleration of 20 to 1000 g for 5 to 10 minutes to obtain a centrifuged product; wherein the upper yellow portion of the centrifuged product is the dopamine-modified plasma matrix;

[0034] Preferably, the centrifugal acceleration is 20 to 950 g, and the centrifugal time is 2 to 8 min.

[0035] In some embodiments of the present invention, a method for preparing a dopamine-modified plasma matrix comprises the following steps:

[0036] (1) injecting dopamine into a blood collection tube, sterilizing and vacuum treating the tube, and obtaining a blood collection tube containing dopamine;

[0037] Preferably, the amount of dopamine added is 10 to 1000 μg, for example, 39 μg, 197 μg, 448 μg, 629 μg, 793 μg, 858 μg, etc.; the material for preparing the blood collection tube is selected from plastic or glass.

[0038] (2) collecting 7 to 50 mL of blood into the blood collection tube in step (1);

[0039] Preferably, the ratio of the mass of dopamine in step (1) to the volume of blood in step (2) is in the range of (100 ng:10 mL) to (10 μg:10 mL).

[0040] (3) mixing the blood collection tube containing blood obtained in step (2) uniformly, and centrifuging at a centrifugal acceleration of 20 to 1000 g for 5 to 10 minutes to obtain a centrifuged product; wherein the upper yellow portion of the centrifuged product is the dopamine-modified plasma matrix;

[0041] Preferably, the centrifugal acceleration is 20 to 950 g, and the centrifugal time is 2 to 8 min.

[0042] In some embodiments of the present invention, a method for preparing a dopamine-modified plasma matrix comprises the following steps:

[0043] (1) Select and clean blood collection tubes;

[0044] Preferably, the material used to prepare the blood collection tube is selected from plastic or glass.

[0045] (2) collecting 7 to 50 mL of blood into the blood collection tube in step (1), centrifuging, and obtaining a liquid plasma matrix;

[0046] (3) mixing the liquid plasma matrix obtained in step (2) with dopamine to prepare a dopamine-modified plasma matrix;

[0047] Preferably, the amount of dopamine added is 10 to 1000 μg, for example, 39 μg, 197 μg, 448 μg, 629 μg, 793 μg, 858 μg, etc.

[0048] In some embodiments of the present invention, a method for preparing a dopamine-modified plasma matrix comprises the following steps:

[0049] (1) Collect 7-50 mL of blood and place it in a blood collection tube;

[0050] Preferably, the material used to prepare the blood collection tube is selected from plastic or glass.

[0051] (2) centrifuging the blood collection tube containing blood obtained in step (1) at a centrifugal acceleration of 20 to 1000 g for 5 to 10 minutes to obtain a centrifugal product; wherein the upper yellow portion of the centrifugal product is the solid plasma matrix;

[0052] Preferably, the centrifugal acceleration is 20 to 950 g, and the centrifugal time is 2 to 8 min.

[0053] (3) collecting the solid plasma matrix obtained in step (2) and pressing it into a film using a pressing device box to prepare a solid plasma matrix membrane;

[0054] (4) immersing the solid plasma matrix obtained in step (3) in a dopamine solution to obtain a dopamine-modified plasma matrix;

[0055] Wherein, the concentration range of the dopamine solution is 10 μmol / L to 500 μmol / L.

[0056] In some embodiments of the present invention, a process diagram of a method for preparing a dopamine-modified plasma matrix bone block is as follows: Figure 1 As shown, the specific steps include:

[0057] (1) placing different volumes of blood in different glass blood collection tubes or plastic blood collection tubes and centrifuging them to prepare liquid plasma matrix and solid plasma matrix respectively;

[0058] (2) in a pressing device box, pressing the solid plasma matrix obtained in step (1) into a solid plasma matrix membrane;

[0059] (3) cutting the solid plasma matrix membrane prepared in step (2) into pieces to obtain solid plasma matrix membrane fragments;

[0060] (4) mixing dopamine and Bio-Oss bone powder to obtain a mixture of dopamine and Bio-Oss bone powder;

[0061] (5) Mixing the liquid plasma matrix obtained in step (1), the mixture of dopamine and Bio-Oss bone powder obtained in step (4), and the solid plasma matrix membrane fragments obtained in step (3) to prepare dopamine-modified plasma matrix bone blocks.

[0062] In order to further illustrate the effect of the present invention, specific embodiments are used for illustration below.

[0063] Example 1

[0064] This embodiment provides a method for preparing a dopamine-modified plasma matrix, comprising the following steps:

[0065] (1) spraying a dopamine solution with a concentration of 50 μmol / L into a glass blood collection tube, sterilizing and vacuum treating the tube to obtain a blood collection tube containing dopamine;

[0066] (2) Collect 10 mL of blood and place it in the blood collection tube in step (1);

[0067] (3) mixing the blood collection tube containing blood obtained in step (2) uniformly, and centrifuging at a centrifugal acceleration of 700 g for 8 minutes to obtain a centrifugal product;

[0068] (4) separating and collecting the upper yellow portion of the centrifuged product obtained in step (3) to obtain a dopamine-modified plasma matrix;

[0069] (5) in a membrane pressing device box, pressing the dopamine-modified plasma matrix obtained in step (4) into a membrane to obtain a dopamine-modified plasma matrix membrane;

[0070] (6) The dopamine-modified plasma matrix membrane obtained in step (5) was subjected to a tensile strength test, and the test results were as follows: Figure 2 shown.

[0071] according to Figure 2 The data analysis in the results obtained lead to the following conclusion: the mechanical properties of the dopamine-modified plasma matrix obtained by the preparation method of the embodiment of the present invention are better than those of the plasma matrix.

[0072] Comparative Example 1

[0073] (1) Collect 10 mL of blood and place it in a glass blood collection tube;

[0074] (2) centrifuging the blood collection tube obtained in step (1) at a centrifugal acceleration of 700 g for 8 min to obtain a centrifugal product;

[0075] (3) separating and collecting the upper yellow portion of the centrifugal product obtained in step (2) to obtain a plasma matrix;

[0076] (4) in a membrane pressing device box, pressing the plasma matrix obtained in step (3) into a membrane to obtain a plasma matrix membrane;

[0077] (5) The plasma matrix membrane obtained in step (4) was subjected to tensile strength test, and the test results were as follows: Figure 3 shown.

[0078] Example 2

[0079] This embodiment provides a method for preparing a dopamine-modified plasma matrix bone block, comprising the following steps:

[0080] (1) Collect 50 mL of blood and place it in a plastic blood collection tube;

[0081] (2) centrifuging the blood collection tube obtained in step (1) at a centrifugal acceleration of 700 g for 8 minutes to obtain a centrifugal product;

[0082] (3) separating and collecting the upper yellow portion of the centrifugal product obtained in step (2) to obtain a solid plasma matrix;

[0083] (4) in a membrane pressing device box, pressing the solid plasma matrix obtained in step (4) into a solid plasma matrix membrane;

[0084] (5) cutting the solid plasma matrix membrane obtained in step (4) into pieces to obtain solid plasma matrix membrane fragments;

[0085] (6) Collect 50 mL of blood into a glass blood collection tube and centrifuge at 700 g for 8 min to obtain a liquid plasma matrix;

[0086] (7) 1 mL of the liquid plasma matrix obtained in step (6), 10 μg of dopamine, 0.25 g of Bio-Oss bone powder, and 5 g of the fragments of the solid plasma matrix membrane obtained in step (5) were mixed to prepare a dopamine-modified plasma matrix bone block. Figure 3 shown.

[0087] (8) The dopamine-modified plasma matrix bone block obtained in step (7) is subjected to a tensile property test, and the test result is as follows: Figure 4 shown.

[0088] according to Figure 3 The data analysis in the results obtained lead to the following conclusion: the dopamine-modified plasma matrix obtained by the preparation method of the embodiment of the present invention has a high degree of cross-linking.

[0089] according to Figure 4 The data analysis in the results obtained lead to the following conclusion: the biomechanical properties of the dopamine plasma-modified matrix bone block obtained by the preparation method of the embodiment of the present invention are better than those of the plasma matrix bone block.

[0090] Comparative Example 2

[0091] (1) Collect 50 mL of blood and place it in a plastic blood collection tube;

[0092] (2) centrifuging the blood collection tube obtained in step (1) at a centrifugal acceleration of 700 g for 8 minutes to obtain a centrifugal product;

[0093] (3) separating and collecting the upper yellow portion of the centrifugal product obtained in step (2) to obtain a solid plasma matrix;

[0094] (4) in a membrane pressing device box, pressing the solid plasma matrix obtained in step (3) into a solid plasma matrix membrane;

[0095] (5) cutting the solid plasma matrix membrane obtained in step (4) into pieces to obtain solid plasma matrix membrane fragments;

[0096] (6) Collect 50 mL of blood into a glass blood collection tube and centrifuge at 700 g for 8 min to obtain a liquid plasma matrix;

[0097] (7) 1 mL of the liquid plasma matrix obtained in step (6), 0.25 g of Bio-Oss bone powder, and 5 g of the solid plasma matrix membrane fragments obtained in step (5) were mixed to prepare plasma matrix bone blocks.

[0098] (8) The plasma matrix bone block obtained in step (7) is subjected to a tensile property test, and the test result is as follows: Figure 4 shown.

[0099] In summary, the dopamine-modified plasma matrix, plasma matrix bone block and preparation method thereof provided in the embodiment of the present invention, by adding dopamine to the plasma matrix, the cross-linking between the plasma matrix is ​​improved by using dopamine, and dopamine makes the fiber network cross-linking in the plasma matrix membrane more dense, and the bone block containing the dopamine-modified plasma matrix has better cross-linking, toughness, tensile strength and longer degradation time; and solves the problem of insufficient strength of the current plasma matrix bone block. In addition, since dopamine has good biocompatibility, it can enhance the binding of platelets; and it will not affect the cell activity and the osteogenic efficacy of bone substitute materials; therefore, controlling the dosage of dopamine can promote the growth of bone formation.

[0100] It should be noted that, in this article, relational terms such as "first" and "second" are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, the elements defined by the sentence "comprise a ..." do not exclude the existence of other identical elements in the process, method, article or device including the elements.

[0101] The above description is only a specific embodiment of the present invention, so that those skilled in the art can understand or implement the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments described herein, but should conform to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A method for preparing a dopamine-modified plasma matrix, characterized in that: The preparation method includes any one of the following methods I to III: Method I: Spraying or injecting dopamine into the blood collection tube to obtain a blood collection tube containing dopamine; Adding blood into the blood collection tube containing dopamine, centrifuging, and obtaining a dopamine-modified plasma matrix; Or, Method II: The blood is placed in a blood collection tube and centrifuged to obtain a solid plasma matrix; soaking the solid plasma matrix in a dopamine solution to obtain a dopamine-modified plasma matrix; Or, Method III: The blood is placed in a blood collection tube and centrifuged to obtain a liquid plasma matrix; Dopamine and the liquid plasma matrix are mixed evenly to obtain a dopamine-modified plasma matrix.

2. The preparation method according to claim 1, characterized in that: In the method I, The ratio of dopamine mass to blood volume ranges from (100 ng:10 mL) to (10 μg:10 mL).

3. The preparation method according to claim 1, characterized in that: In the method II, The concentration range of the dopamine solution is 10 μmol / L to 500 μmol / L; The mass ratio of the solid plasma matrix to the volume ratio of the dopamine solution is in the range of (5 g:1 mL) to (15 g:1 mL).

4. The preparation method according to claim 1, characterized in that: In the method III, The mass ratio of the dopamine to the liquid plasma matrix ranges from (100 ng:10 g) to (10 μg:10 g).

5. The preparation method according to any one of claims 1 to 4, characterized in that: The centrifugal acceleration of the centrifugation is 20 to 1000 g, and the centrifugal time is 5 to 10 minutes; Preferably, the centrifugal acceleration of the centrifugation is 20 to 950 g, and the centrifugal time is 2 to 8 min.

6. The preparation method according to any one of claims 1 to 5, characterized in that: The material for preparing the blood collection tube is selected from plastic or glass.

7. A dopamine-modified plasma matrix, characterized in that The dopamine-modified plasma matrix is ​​obtained by the preparation method according to any one of claims 1 to 6.

8. A method for preparing a dopamine-modified plasma matrix bone block, characterized in that: include: The blood is placed in a blood collection tube and centrifuged to obtain a solid plasma matrix and a liquid plasma matrix respectively; The solid plasma matrix, the liquid plasma matrix, dopamine and Bio-Oss bone powder are mixed to prepare a dopamine-modified plasma matrix bone block; Among them, the mass ratio range of solid plasma matrix, liquid plasma matrix, dopamine and Bio-Oss bone powder is (5g~10g):(1mL~2mL):(10ng~50μg):0.25g.

9. The method for preparing dopamine-modified plasma matrix bone blocks according to claim 8, characterized in that: include: placing a first volume of blood in a glass blood collection tube and centrifuging to obtain a liquid plasma matrix; placing a second volume of blood in a plastic blood collection tube and centrifuging to obtain a solid plasma matrix; In a pressing device box, pressing the solid plasma matrix into a plasma matrix film; Cutting the plasma matrix membrane into pieces to obtain plasma matrix membrane fragments; mixing dopamine and Bio-Oss bone meal to obtain a mixture of dopamine and Bio-Oss bone meal; The mixture of dopamine and Bio-Oss bone powder, plasma matrix membrane fragments and liquid plasma matrix are uniformly mixed to obtain dopamine-modified plasma matrix bone blocks.

10. A dopamine-modified plasma matrix bone block, characterized in that: The dopamine-modified plasma matrix bone block is obtained by the preparation method of the dopamine-modified plasma matrix bone block according to claim 8 or 9.